PCM
BSX icon

Pointe Capital Management’s Boston Scientific BSX Stock Holding History

Pointe Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,350
Closed -$67.5K – 188
2023
Q1 		$67.5K Buy
+1,350
New +$63.6K 0.05% 212

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Pointe Capital Management's BSX Position: Q2 2023 in Review

Pointe Capital Management sold out of Boston Scientific (BSX) in Q2 2023, closing a stake of 1,350 shares — an estimated $67.5K sold.

Pointe Capital Management first reported a position in BSX in Q1 2023 and held it in 1 quarter. The position peaked at $67.5K in Q1 2023. 1,066 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

  • Pointe Capital Management reported no remaining Boston Scientific position as of Q2 2023 after selling out during the quarter.
  • Pointe Capital Management sold 1,350 Boston Scientific shares in Q2 2023, an estimated $67.5K.
  • Pointe Capital Management first reported a position in Boston Scientific in Q1 2023 and held it in 1 quarter.
  • Pointe Capital Management's Boston Scientific position peaked at $67.5K in Q1 2023.
  • 1,066 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on Pointe Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.